CME Financial Statements & Analysis
Complete financial statements for CME including income statement, balance sheet, and cash flow statement. Analyze CME's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
59
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
9.9% ↑
Net Income
9.3% ↑
Gross Margin
1.2% ↑
Operating Margin
4.1% ↑
Balance Sheet
Current Ratio
-0.9% ↓
Debt to Equity
-10.9% ↑
Asset Turnover
3.7% ↑
Cash Flow
Operating Cash Flow
6.9% ↑
Net Cash Flow
119.4% ↑
Free Cash Flow
6.5% ↑
Cash Flow to Debt
21.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 5.58B | 6.13B | 9.9% | |
| Gross Profit | 4.75B | 5.28B | 11.1% | |
| Operating Income | 3.44B | 3.93B | 14.4% | |
| Net Income | 3.23B | 3.53B | 9.3% | |
| EPS | 8.87 | 9.69 | 9.2% | |
| EBITDA | 4.67B | 5.04B | 8.0% | |
| Gross Margin | 85.15% | 86.13% | 1.2% | |
| Operating Margin | 61.58% | 64.13% | 4.1% | |
| Net Income Margin | 57.83% | 57.52% | 0.5% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 6.13B | 5.58B | 5.02B | 4.69B | 4.88B |
| Gross Profit | 5.28B | 4.75B | 4.27B | 3.85B | 4.03B |
| Operating Income | 3.93B | 3.44B | 3.02B | 2.65B | 2.64B |
| Net Income | 3.53B | 3.23B | 2.69B | 2.64B | 2.11B |
| EPS | 9.69 | 8.87 | 7.41 | 7.3 | 5.88 |
| EBITDA | 5.04B | 4.67B | 4.02B | 3.93B | 3.35B |
| Gross Margin | 86.13% | 85.15% | 85.00% | 82.15% | 82.46% |
| Operating Margin | 64.13% | 61.58% | 60.08% | 56.40% | 54.01% |
| Net Income Margin | 57.52% | 57.83% | 53.61% | 56.22% | 43.11% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |